Alphatec Holdings, Inc. (ATEC)
$
12.45
-0.03 (-0.24%)
Key metrics
Financial statements
Free cash flow per share
-0.5500
Market cap
1.8 Billion
Price to sales ratio
2.8403
Debt to equity
10.5296
Current ratio
2.7547
Income quality
0.0680
Average inventory
173.1 Million
ROE
-2.5763
Technology
Technology – consumer electronics
Largecap
With a market cap of 121,78 bil stock is ranked 1
Low risk
ISS score of this stock is ranked 1
Company description
Profile
Alphatec Holdings, Inc. is a medical technology company that specializes in the design, development, and advancement of surgical technologies for spinal disorder treatments. The company's product offerings include the SafeOp Neural InformatiX System, aimed at minimizing intraoperative nerve injury risk, and the Sigma transforaminal lumbar interbody fusion pedicle-based access system, which allows for direct visualization of anatomical landmarks. Additionally, the portfolio features the Sigma PTP Access and Patient Positioning System, the squadron lateral retractor to enhance patient outcomes, and the Invictus Spinal Fixation System, designed for thoracolumbar fixation to address various pathologies. Further bolstering its innovations, the Invictus MIS SingleStep System enables minimally invasive pedicle screw placements. Alphatec also provides modular fixation solutions with the Invictus Modular Fixation Systems, along with the OsseoScrew system that aims to restore spinal column integrity. Other key offerings include the Arsenal spinal fixation system for a range of conditions, the Aspida Anterior Lumbar Plating System for anterior lumbar interbody fusion, the AMP Anti-Migration Plate, the OCT Spinal Fixation System, the Trestle Luxe Anterior Cervical Plate System, and the Insignia Anterior Cervical Plate System. Moreover, Alphatec produces IdentiTi Porous Ti, Transcend Lateral, and Battalion Posterior Interbody Implants, along with a range of biologics such as Cervical Structural Allograft Spacers and the 3D ProFuse Demineralized Bone Scaffold. The financial data pertains to the fiscal year 2024 where the company incurred an income tax expense of $50,000.00 indicating its tax obligations, while its net income ratio is -0.27 reflecting the company's profitability margin. Additionally, Alphatec earned an interest income of $0.00 showcasing its financial investments, while total costs and expenses amount to $747,731,000.00 highlighting overall spending. The company's stock is affordable at $12.45 making it suitable for budget-conscious investors, while a high average trading volume of 2,243,653.00 indicates strong liquidity. With a market capitalization of $1,819,853,850.00 Alphatec is classified as a small-cap player. It is a key player in the Medical - Devices industry, contributing significantly to the overall market landscape, and it belongs to the Healthcare sector, where it drives innovation and growth.
What is Alphatec Holdings, Inc. (ATEC)'s stock forecast?
Analysts predict Alphatec Holdings, Inc. stock to fluctuate between $4.88 (low) and $13.14 (high) in the next 365 days, reflecting market expectations and potential volatility.
What is Alphatec Holdings, Inc.'s market capitalization?
As of 2025-05-27, Alphatec Holdings, Inc.'s market cap is $1,819,853,850, based on 146,173,000 outstanding shares.
How does Alphatec Holdings, Inc. compare to competitors like Eli Lilly & Co.?
Compared to Eli Lilly & Co., Alphatec Holdings, Inc. has a Lower Market-Cap, indicating a difference in performance.
How can I buy Alphatec Holdings, Inc. (ATEC) stock?
To buy Alphatec Holdings, Inc. (ATEC) stock: Open a brokerage account (e.g., Robinhood, TD Ameritrade, E-Trade). Search for ATEC. Place an order (Market, Limit, etc.).
What is the best time to invest in Alphatec Holdings, Inc.?
The best time to invest depends on market trends and technical indicators, which show a Bearish trend based on economic conditions and company performance.
Has Alphatec Holdings, Inc. stock ever split?
Alphatec Holdings, Inc.'s last stock split was 1:12 on 2016-08-25.
How did Alphatec Holdings, Inc. perform in the last earnings report?
Revenue: $611,562,000 | EPS: -$1.13 | Growth: -26.62%.
Where can I find Alphatec Holdings, Inc.'s investor relations reports?
Visit https://www.atecspine.com/investor-relations for detailed financial reports.
Where can I find historical stock prices for Alphatec Holdings, Inc.?
You can explore historical data from here
What is the all-time high and low for Alphatec Holdings, Inc. stock?
All-time high: $19.36 (2021-03-23) | All-time low: $4.88 (2024-10-10).
What are the key trends affecting Alphatec Holdings, Inc. stock?
Key trends include market demand, economic conditions, interest rates, and industry competition, which influence the stock's performance.
News
globenewswire.com
8 days ago
RESTON, Va., May 20, 2025 (GLOBE NEWSWIRE) -- Bowman Consulting Group Ltd.
seekingalpha.com
a month ago
Alphatec Holdings, Inc. (NASDAQ:ATEC ) Q1 2025 Earnings Conference Call May 1, 2025 4:30 PM ET Company Participants Pat Miles - Chairman and CEO Todd Koning - CFO Conference Call Participants Brooks O'Neil - Lake Street Capital Markets Vik Chopra - Wells Fargo Matt Miksic - Barclays Mathew Blackman - Stifel Young Li - Jefferies Eric Anderson - TD Cowen David Saxon - Needham Sean Lee - H.C. Wainwright Operator Good afternoon, everyone, and welcome to the webcast of ATEC's First Quarter Financial Results.
zacks.com
a month ago
Alphatec (ATEC) came out with a quarterly loss of $0.23 per share versus the Zacks Consensus Estimate of a loss of $0.12. This compares to loss of $0.34 per share a year ago.
businesswire.com
a month ago
CARLSBAD, Calif.--(BUSINESS WIRE)--Alphatec Holdings, Inc. (Nasdaq: ATEC), a provider of innovative solutions dedicated to revolutionizing the approach to spine surgery, today announced financial results for the quarter ended March 31, 2025, and recent corporate highlights. First Quarter 2025 Financial Results Quarter Ended March 31, 2025 Total revenue $169 million GAAP gross margin 69% Non-GAAP gross margin 70% GAAP operating expenses $160 million Non-GAAP operating expenses $124 million GAA.
businesswire.com
a month ago
CARLSBAD, Calif.--(BUSINESS WIRE)--Alphatec Holdings, Inc. (Nasdaq: ATEC), a provider of innovative solutions dedicated to revolutionizing the approach to spine surgery, today announced the commercial launch of its Prone TransPsoas (PTP™) Corpectomy system. This milestone marks the continued evolution of ATEC's PTP surgical approach, expanding its capabilities to include deformity and corpectomy procedures for complex pathologies of the thoracolumbar spine. “PTP Corpectomy represents a signific.
seekingalpha.com
3 months ago
In recent years, Alphatec Holdings or "ATEC" has outperformed sales expectations on a regular basis and successfully taken share in the $8 billion U.S. spinal disorder treatment market. The company continues to benefit from M&A-related disruptions at key competitors, which has created opportunities for ATEC to grab additional market share. Following years of elevated cash usage, the company managed to generate free cash flow in the final quarter of 2024.
businesswire.com
3 months ago
CARLSBAD, Calif.--(BUSINESS WIRE)--Alphatec Holdings, Inc. (Nasdaq: ATEC), a provider of innovative solutions dedicated to revolutionizing the approach to spine surgery, today announced the pricing of its offering of $350,000,000 aggregate principal amount of 0.75% convertible senior notes due 2030 (the “notes”) in a private offering to qualified institutional buyers pursuant to Rule 144A under the Securities Act of 1933, as amended (the “Securities Act”). The offering size was increased from t.
seekingalpha.com
3 months ago
Alphatec Holdings, Inc. (NASDAQ:ATEC ) Q4 2024 Earnings Conference Call February 26, 2025 4:30 PM ET Company Participants Pat Miles - Chairman and CEO Todd Koning - CFO Conference Call Participants Brooks O'Neil - Lake Street Capital Markets Vik Chopra - Wells Fargo Eric Anderson - TD Cowen Phillip Dantoin - Piper Sandler Matt Miksic - Barclays Caitlin Cronin - Canaccord Genuity Jason Wittes - ROTH David Saxon - Needham Kallum Titchmarsh - Morgan Stanley Operator Good afternoon, everyone, and welcome to the webcast of ATEC's Fourth Quarter Financial Results. We would like to remind everyone that participants on the call will make forward-looking statements.
zacks.com
3 months ago
Alphatec (ATEC) came out with a quarterly loss of $0.23 per share versus the Zacks Consensus Estimate of a loss of $0.18. This compares to loss of $0.37 per share a year ago.
businesswire.com
3 months ago
CARLSBAD, Calif.--(BUSINESS WIRE)--Alphatec Holdings, Inc. (Nasdaq: ATEC), a provider of innovative solutions dedicated to revolutionizing the approach to spine surgery, announced today that management will participate in the following investor conferences: The Canaccord Genuity Musculoskeletal Conference in San Diego, CA, on March 10 2025, with a fireside chat at 10:30am PT The Barclays Global Healthcare Conference in Miami, FL, on March 11, 2025, with a fireside chat at 3:00pm ET If available.
See all news
